Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design

被引:70
作者
Carbone, C. [1 ]
Tomasello, B. [1 ]
Ruozi, B. [2 ]
Renis, M. [1 ]
Puglisi, G. [1 ]
机构
[1] Univ Catania, Fac Pharm, Dept Drug Sci, I-95100 Catania, Italy
[2] Univ Modena & Reggio Emilia, Fac Pharm, Dept Pharmaceut Sci, I-41121 Modena, Italy
关键词
SLN; Phase inversion temperature; DOTAP; Cetyl palmitate; Zeta potential; Factorial planning; MEDIATED GENE-TRANSFER; NANO-EMULSIONS; DELIVERY; FORMULATION; DNA;
D O I
10.1016/j.ejmech.2012.01.001
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The objective of this study was the preparation, physico-chemical characterization and statistical optimization of cationic solid lipid nanoparticles (SLN) prepared by the PIT method as potential carrier for gene therapy, emphasizing the application of factorial design in such a kind of studies. The preliminary screening from a physico-chemical point of view on three cationic lipids (CTAB, DDAB and DOTAP), selected on the basis of their different chemical structure and increasing lipophilicity, allowed us to select SLN with DOTAP, due to its higher zeta potential and smaller particle size. Afterward, a 2(2) full factorial experimental design was developed in order to study the effects of two independent variables (amount of DOTAP and concentration of lipid matrix) and their interaction on mean particle size and zeta potential values. The factorial planning was validated by ANOVA analysis; the correspondence between the predicted values of size and zeta and those measured experimentally confirmed the validity of the design and the equation applied for its resolution. The factorial design showed a significant influence of the independent variables on the selected parameters; in particular, a higher effect of DOTAP was observed on zeta potential value. Different dilutions of the optimized SLN containing 7% w/w of cutina CP and 1% w/w of DOTAP, with size and zeta potential values respectively of 462.9 nm and 50.8 mV, were in vitro examined to evaluate the possible cytotoxicity on two models of cell cultures: human prostate cancer androgen-non-responsive DU-145 cells and primary cultures of rat astrocytes. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:110 / 117
页数:8
相关论文
共 35 条
[1]
Nano-emulsions and nanocapsules by the PIT method: An investigation on the role of the temperature cycling on the emulsion phase inversion [J].
Anton, Nicolas ;
Gayet, Pascal ;
Benoit, Jean-Pierre ;
Saulnier, Patrick .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 344 (1-2) :44-52
[2]
The universality of low-energy nano-emulsification [J].
Anton, Nicolas ;
Vandamme, Thierry F. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 377 (1-2) :142-147
[3]
Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design [J].
Bhavsar, MD ;
Tiwari, SB ;
Amiji, MM .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) :422-430
[4]
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery [J].
Bondi, Maria Luisa ;
Azzolina, Antonina ;
Craparo, Emanuela Fabiola ;
Lampiasi, Nadia ;
Capuano, Giulia ;
Giammona, Gaetano ;
Cervello, Melchiorre .
JOURNAL OF DRUG TARGETING, 2007, 15 (04) :295-301
[5]
ON THE EXPERIMENTAL ATTAINMENT OF OPTIMUM CONDITIONS [J].
BOX, GEP ;
WILSON, KB .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1951, 13 (01) :1-45
[6]
Optimization of nanosized silver particle synthesis via experimental design [J].
Chang, Jyh-Shyong ;
Lee, Yuan-Ping ;
Wang, Rong-Chi .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2007, 46 (17) :5591-5599
[7]
Corrias Francesco, 2011, Recent Pat Drug Deliv Formul, V5, P201
[8]
Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons [J].
da Cruz, MTG ;
Simoes, S ;
de Lima, MCP .
EXPERIMENTAL NEUROLOGY, 2004, 187 (01) :65-75
[9]
Design of solid lipid nanoparticles for gene delivery into prostate cancer [J].
de Jesus, Marcelo Bispo ;
Ferreira, Carmen Verissima ;
de Paula, Eneida ;
Hoekstra, Dick ;
Zuhorn, Inge S. .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (01) :E89-E90
[10]
Solid lipid nanoparticles:: Formulation factors affecting cell transfection capacity [J].
del Pozo-Rodriguez, A. ;
Delgado, D. ;
Solinis, M. A. ;
Gascon, A. R. ;
Pedraz, J. L. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 339 (1-2) :261-268